POLYMORPHISM OF ANTIGEN-PROCESSING (TAP, LMP) AND HLA CLASS-II GENES IN CELIAC-DISEASE

被引:54
作者
DJILALISAIAH, I
CAILLATZUCMAN, S
SCHMITZ, J
CHAVESVIEIRA, ML
BACH, JF
机构
[1] HOP NECKER ENFANTS MALAD,INSERM,U25,F-75015 PARIS,FRANCE
[2] HOP NECKER ENFANTS MALAD,DEPT PEDIAT,PARIS,FRANCE
关键词
D O I
10.1016/0198-8859(94)90015-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to CD is strongly associated with particular HLA class II molecules. However, additive genetic factors are likely to be required for the development of the disease. The polymorphic TAP and LMP genes, located within the HLA class II region, are involved in the antigen presentation pathway and thus represent candidate susceptibility genes. HLA class II DRB1, DRB3, DQA1, DQB1, and DPB1 as well as TAP1, TAP2, and LMP2 polymorphism was studied in 80 Caucasian CD patients and 213 normal controls by DNA oligotyping. The DQB1*0201 allele was found in 96.3% of CD patients and provided the highest risk (RR = 50), whereas only 89% of CD patients carried the DQ alpha 501/beta 201 heterodimer(RR = 30). The participation of the DRB3 and DPB 1 locus was ruled out as it was attributed to a linkage disequilibrium on the DR3 haplotype. TAP1 and LMP2 allelic distribution was not significantly different among CD patients and controls. The TAP2-C allele was completely absent from the CD population, while it was found in 22.5% of controls. Although linkage disequilibrium between TAP2 and class II loci clearly exists in some haplotypes, TAP could act as additional susceptibility genes.
引用
收藏
页码:8 / 16
页数:9
相关论文
共 55 条
[11]   ALLELIC VARIANTS OF THE HUMAN PUTATIVE PEPTIDE TRANSPORTER INVOLVED IN ANTIGEN PROCESSING [J].
COLONNA, M ;
BRESNAHAN, M ;
BAHRAM, S ;
STROMINGER, JL ;
SPIES, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3932-3936
[12]   REASSESSMENT OF HLA ASSOCIATION WITH CELIAC-DISEASE IN SPECIAL REFERENCE TO THE DP ASSOCIATION [J].
COLONNA, M ;
MANTOVANI, W ;
CORAZZA, GR ;
BARBONI, P ;
GASBARRINI, G ;
FERRARA, GB ;
TOSI, R ;
TANIGAKI, N .
HUMAN IMMUNOLOGY, 1990, 29 (04) :263-274
[13]   A HIGH-FREQUENCY OF THE A30, B18, DR3, DRW52, DQW2 EXTENDED HAPLOTYPE IN SARDINIAN CELIAC-DISEASE PATIENTS - FURTHER EVIDENCE THAT DISEASE SUSCEPTIBILITY IS CONFERRED BY DQ A1-STAR-0501, B1-STAR-0201 [J].
CONGIA, M ;
FRAU, F ;
LAMPIS, R ;
FRAU, R ;
MELE, R ;
CUCCA, F ;
MUNTONI, F ;
PORCU, S ;
BOI, F ;
CONTU, L ;
LANASA, G ;
MULARGIA, M ;
PIRASTU, M ;
CAO, A ;
DEVIRGILLIS, S .
TISSUE ANTIGENS, 1992, 39 (02) :78-83
[14]  
DEMARCHI M, 1984, HISTOCOMPATIBILITY T, P359
[15]   MHC CLASS-II REGION ENCODING PROTEINS RELATED TO THE MULTIDRUG RESISTANCE FAMILY OF TRANSMEMBRANE TRANSPORTERS [J].
DEVERSON, EV ;
GOW, IR ;
COADWELL, WJ ;
MONACO, JJ ;
BUTCHER, GW ;
HOWARD, JC .
NATURE, 1990, 348 (6303) :738-741
[16]   GLIADIN UPTAKE IN HUMAN ENTEROCYTES - DIFFERENCES BETWEEN CELIAC PATIENTS IN REMISSION AND CONTROL INDIVIDUALS [J].
FRIIS, S ;
DABELSTEEN, E ;
SJOSTROM, H ;
NOREN, O ;
JARNUM, S .
GUT, 1992, 33 (11) :1487-1492
[17]   A PROTEASOME-RELATED GENE BETWEEN THE 2 ABC TRANSPORTER LOCI IN THE CLASS-II REGION OF THE HUMAN MHC [J].
GLYNNE, R ;
POWIS, SH ;
BECK, S ;
KELLY, A ;
KERR, LA ;
TROWSDALE, J .
NATURE, 1991, 353 (6342) :357-360
[18]   A SIMPLE AND EFFICIENT NON-ORGANIC PROCEDURE FOR THE ISOLATION OF GENOMIC DNA FROM BLOOD [J].
GRIMBERG, J ;
NAWOSCHIK, S ;
BELLUSCIO, L ;
MCKEE, R ;
TURCK, A ;
EISENBERG, A .
NUCLEIC ACIDS RESEARCH, 1989, 17 (20) :8390-8390
[19]   CELIAC-DISEASE IS ASSOCIATED WITH AN EXTENDED HLA-DR3 HAPLOTYPE WHICH INCLUDES HLA-DPW1 [J].
HALL, MA ;
LANCHBURY, JSS ;
BOLSOVER, WJ ;
WELSH, KI ;
CICLITIRA, PJ .
HUMAN IMMUNOLOGY, 1990, 27 (03) :220-228
[20]  
HEITZEL PAS, 1987, TISSUE ANTIGENS, V30, P18